Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA
Tilak Sundaresan(Kaiser Permanente San Francisco Medical Center), Daniel A. Haber(Howard Hughes Medical Institute), Erin J. Silva(Massachusetts General Hospital), Zongli Zheng(City University of Hong Kong), Ravi Kapur(Harvard University), Taronish D. Dubash(Harvard University), Aditya Bardia(UCLA Health), Douglas B. Fox(Harvard University), Matthew Liebers(Massachusetts General Hospital), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Mehmet Toner(Center for Cancer Research), Nicola Aceto(ETH Zurich), John Iafrate(Harvard University)
Cited by 18
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k